American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Takeaim lymphoma: An open-label, dose escalation and expansion trial of emavusertib (CA-4948) in combination with ibrutinib in patients with relapsed or refractory hematologic malignancies
    Meeting Abstract

    Grommes, C.; Tun, H.; Rosenthal, A. C.; Lunning, M. A.; Ramchandren, R.; Regales, L.; Zhao, W.; Lane, M.; Wang, C.; von Roemeling, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Final results of a phase I/II trial of carfilzomib + R-CHOP for frontline treatment of patients with non-germinal center diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Hill, B. T.; Torka, P.; Hernandez-Ilizaliturri, F. J.; Dean, R. M.; Jagadeesh, D.; Karamlou, K.; Fu, C. L.; Winter, A.; Krauspe, E.; Zhou, J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The value of collaboration with patient advocacy organizations to enhance initiatives focused on patient-centered care and improve outcomes in chronic lymphocytic leukemia
    Meeting Abstract

    Deluca, C.; Beyer, M.; Drew, H.; Murray, J.; Massey, J.; Koffman, B.; Battiato, K.; Gribben, J. G.; Lamanna, N.; Russomanno, C.
    Blood (2023)

    Fulltext@MSK | Save
  • Fixed-duration pirtobrutinib combined with venetoclax ± rituximab in relapsed/refractory chronic lymphocytic leukemia: Updated results, including MRD data, from the BRUIN phase 1b study
    Meeting Abstract

    Roeker, L. E.; Woyach, J. A.; Cheah, C. Y.; Coombs, C. C.; Shah, N. N.; Wierda, W. G.; Patel, M.; Tsai, D. E.; Nair, B.; Wang, C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Cost per responder analysis of patients with lenalidomide-refractory multiple myeloma who received cilta-cel from the CARTITUDE-4 Trial
    Meeting Abstract

    Hansen, D. K.; Lu, X.; Castaneda, O.; Sorensen, S.; Usmani, S. Z.; Zhang, E.; Huo, S.; Jagannath, S.
    Blood (2023)

    Fulltext@MSK | Save
  • Preconditioning single high-dose palifermin alters the posttransplant inflammatory cytokine profile
    Meeting Abstract

    Schulz, E.; Holtzman, N. G.; Ostojic, A.; Pirsl, F.; Steinberg, S. M.; Curtis, L. M.; Shaffer, B. C.; Heller, T.; Carpenter, A.; Hakim, F. T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Inhibition of toll-like receptor 4 (TLR4) promotes erythroid and myeloid differentiation in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML)
    Meeting Abstract

    Fromowitz, A.; Aluri, S.; Lugo, J. D. G.; Rabinovich, E.; Ramachandra, N.; Aminov, S.; Sahu, S.; Mitchell, S. G.; Aggarwal, R.; Ajibade, O.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • SARS-CoV-2 infection does not lead to progression of monoclonal gammopathy of undetermined significance: Results from the population-based iStopMM screening study
    Meeting Abstract

    Palmason, R.; Ekberg, S.; Eythorsson, E.; Rögnvaldsson, S.; Thorsteinsdottir, S.; Crowther, M.; Reed, E. R.; Oskarsson, J.; Sigurdardottir, G. A.; Aspelund, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical Factors but not somatic mutations predict for survival in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplant: Analysis of the North American myelofibrosis transplant outcome (NAMTO) study
    Meeting Abstract

    Ajufo, H.; Derkach, A.; Rampal, R. K.; Famulare, C.; Nemirovsky, D.; Chervin, J.; Ho, V.; Gupta, V.; Viswabandya, A.; Deeg, H. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Engraftment syndrome during autologous stem cell transplant in Hodgkin lymphoma patients treated with checkpoint inhibitors: A multi-center retrospective analysis
    Meeting Abstract

    Taranto, E.; Hwang, W. T.; Alfaro, M.; Surapaneni, A. S.; Gill, S. K.; Feldman, T.; Randall, M. P.; Spinner, M. A.; Furqan, F.; Shah, N. N.; more...
    Blood (2023)

    Fulltext@MSK | Save